Publications by authors named "K J Connolly"

Aims: Despite receiving guideline-directed medical heart failure (HF) therapy, patients with pulmonary hypertension associated with left heart disease (PH-LHD) experience higher mortality and hospitalization rates than the general HF population. AZD3427 is a functionally selective, long-acting mimetic of relaxin, a hormone that has the potential to induce vasodilation and prevent fibrosis. In a phase 1b study conducted in patients with HF, AZD3427 demonstrated a favourable safety and pharmacokinetic profile.

View Article and Find Full Text PDF

Weaning in piglets presents significant physiological and immunological challenges, including gut dysbiosis and increased susceptibility to post-weaning diarrhoea (PWD). Abrupt dietary, environmental, and social changes during this period disrupt the intestinal barrier and microbiota, often necessitating antimicrobial use. Sustainable dietary strategies are critical to addressing these issues while reducing reliance on antimicrobials.

View Article and Find Full Text PDF

Recognising the urgent need to address water scarcity resulting from climate change, there is a growing push to enhance the resilience of water (and related) systems. For instance, policymakers are now urging companies to shift from short-term focused strategies towards long-term approaches to effectively manage water scarcity. This paper utilises a custom-built dynamic multisectoral model to assess the socio-economic impacts at a macro-level of temporary water scarcity.

View Article and Find Full Text PDF

Limited protective immunologic responses to natural infection and a lack of knowledge about mechanisms of protection have hampered development of an effective vaccine. Recent studies in humans and mice have found meningococcal outer membrane vesicle-containing vaccines (OMV) induce cross species immune responses against gonococci and are associated with protection. The exact mechanisms or how humoral and cellular immunity are related to protection, remain unclear.

View Article and Find Full Text PDF
Article Synopsis
  • The recent surge in syphilis cases in the U.S. poses significant public health challenges, particularly due to intermittent shortages of benzathine penicillin, the primary treatment for the infection.
  • Experts from the National Institute of Allergy and Infectious Diseases (NIAID) gathered in February 2024 to explore alternative therapies for treating syphilis, focusing on existing antibiotics with good safety profiles.
  • Workshop discussions highlighted difficulties in designing clinical trials for alternative treatments due to penicillin's high effectiveness and varied patient demographics and health conditions.
View Article and Find Full Text PDF